title: Polyphosphazenes: Multifunctional, Biodegradable Vehicles for Drug and Gene Delivery.
abstract: Poly[(organo)phosphazenes] are a unique class of extremely versatile polymers with a range of applications including tissue engineering and drug delivery, as hydrogels, shape memory polymers and as stimuli responsive materials. This review aims to divulge the basic principles of designing polyphosphazenes for drug and gene delivery and portray the huge potential of these extremely versatile materials for such applications. Polyphosphazenes offer a number of distinct advantages as carriers for bioconjugates; alongside their completely degradable backbone, to non-toxic degradation products, they possess an inherently and uniquely high functionality and, thanks to recent advances in their polymer chemistry, can be prepared with controlled molecular weights and narrow polydispersities, as well as self-assembled supra-molecular structures. Importantly, the rate of degradation/hydrolysis of the polymers can be carefully tuned to suit the desired application. In this review we detail the recent developments in the chemistry of polyphosphazenes, relevant to drug and gene delivery and describe recent investigations into their application in this field.
authors.affiliation: Institute of Polymer Chemistry, Johannes Kepler University, 4060, Leonding, Austria; oliver.brueggemann@jku.at.
authors.forename: Ian
authors.initials: I
authors.lastname: Teasdale
authors.affiliation: Institute of Polymer Chemistry, Johannes Kepler University, 4060, Leonding, Austria; oliver.brueggemann@jku.at.
authors.forename: Oliver
authors.initials: O
authors.lastname: Brüggemann
keywords: biodegradable polymers; drug delivery; gene delivery; nanomedicines; polymer therapeutics; polyphosphazenes
references.citation: Pharm Res. 2010 Dec;27(12):2569-89
references.pmid: 20725771
references.citation: Biomacromolecules. 2010 Aug 9;11(8):2033-8
references.pmid: 20690712
references.citation: Mol Pharm. 2012 May 7;9(5):1109-17
references.pmid: 22494535
references.citation: J Control Release. 1999 Aug 5;60(2-3):249-59
references.pmid: 10425330
references.citation: Biomaterials. 1994 Jun;15(8):563-9
references.pmid: 7948574
references.citation: Bioconjug Chem. 2012 May 16;23(5):958-65
references.pmid: 22463082
references.citation: Bioconjug Chem. 2010 Apr 21;21(4):764-73
references.pmid: 20353169
references.citation: Nat Mater. 2006 Jun;5(6):439-51
references.pmid: 16738681
references.citation: J Am Chem Soc. 2012 Sep 19;134(37):15293-6
references.pmid: 22950530
references.citation: J Control Release. 2005 Dec 5;109(1-3):275-87
references.pmid: 16039747
references.citation: J Control Release. 2000 Mar 1;65(1-2):271-84
references.pmid: 10699287
references.citation: Biomaterials. 2010 Feb;31(6):1349-59
references.pmid: 19879647
references.citation: Biomaterials. 2009 Oct;30(31):6178-92
references.pmid: 19709738
references.citation: J Biomed Mater Res. 1987 Oct;21(10):1231-46
references.pmid: 3693386
references.citation: Adv Drug Deliv Rev. 1998 May 4;31(3):185-196
references.pmid: 10837625
references.citation: Chemistry. 2003 Aug 18;9(16):3833-6
references.pmid: 12916107
references.citation: J Pharm Sci. 2012 Jul;101(7):2382-91
references.pmid: 22487867
references.citation: J Inorg Biochem. 2007 Nov;101(11-12):1931-6
references.pmid: 17709142
references.citation: Anticancer Drugs. 2001 Apr;12(4):275-304
references.pmid: 11335785
references.citation: Adv Drug Deliv Rev. 2010 Feb 17;62(2):272-82
references.pmid: 20005271
references.citation: Adv Drug Deliv Rev. 2013 Jan;65(1):49-59
references.pmid: 23123294
references.citation: Anticancer Drugs. 2000 Oct;11(9):715-25
references.pmid: 11129734
references.citation: J Control Release. 2005 Jun 20;105(1-2):142-50
references.pmid: 15894394
references.citation: Int J Pharm. 2000 Dec 15;211(1-2):57-65
references.pmid: 11137339
references.citation: Acc Chem Res. 2008 Jan;41(1):108-19
references.pmid: 17663526
references.citation: Biomacromolecules. 2010 Apr 12;11(4):927-33
references.pmid: 20302354
references.citation: Int J Pharm. 2006 Aug 17;319(1-2):29-36
references.pmid: 16677786
references.citation: J Biomed Mater Res. 1993 Jul;27(7):963-73
references.pmid: 8360223
references.citation: Biotechnology (N Y). 1991 May;9(5):468-71
references.pmid: 1367311
references.citation: Nat Biotechnol. 2005 Dec;23(12):1517-26
references.pmid: 16333296
references.citation: Clin Pharmacol Ther. 2008 May;83(5):761-9
references.pmid: 17957183
references.citation: Clin Mater. 1993;13(1-4):3-10
references.pmid: 10146238
references.citation: Pharm Res. 2006 Jan;23(1):1-30
references.pmid: 16392022
references.citation: J Control Release. 1998 Mar 31;52(3):227-37
references.pmid: 9743444
references.citation: Bioconjug Chem. 2005 Nov-Dec;16(6):1529-35
references.pmid: 16287251
references.citation: Curr Opin Biotechnol. 2011 Aug;22(4):492-501
references.pmid: 21676609
references.citation: J Control Release. 2010 Oct 1;147(1):144-50
references.pmid: 20654662
references.citation: Vaccine. 1998 Jan;16(1):92-8
references.pmid: 9607015
references.citation: Vet Immunol Immunopathol. 2012 May 15;146(3-4):289-95
references.pmid: 22377627
references.citation: Biomaterials. 1997 Dec;18(23):1565-9
references.pmid: 9430340
references.citation: Small. 2011 Mar 21;7(6):820-9
references.pmid: 21337511
references.citation: J Pharm Pharmacol. 1996 May;48(5):468-73
references.pmid: 8799869
references.citation: Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2011 Jan-Feb;3(1):33-46
references.pmid: 20533517
references.citation: J Control Release. 2003 Jul 31;90(3):303-11
references.pmid: 12880697
references.citation: J Inorg Biochem. 2005 Aug;99(8):1593-601
references.pmid: 15963570
references.citation: J Control Release. 2003 May 20;89(3):483-97
references.pmid: 12737850
references.citation: Mol Immunol. 2012 Jul;51(3-4):292-303
references.pmid: 22521769
references.citation: Int J Pharm. 2012 Jan 17;422(1-2):374-80
references.pmid: 22079718
references.citation: Acta Biomater. 2010 Jun;6(6):1931-7
references.pmid: 20004751
references.citation: Acc Chem Res. 2009 Aug 18;42(8):1141-51
references.pmid: 19555070
references.citation: Adv Drug Deliv Rev. 2003 Apr 25;55(4):467-82
references.pmid: 12706046
references.citation: Biomaterials. 2010 Jun;31(18):4898-908
references.pmid: 20334909
references.citation: Angew Chem Int Ed Engl. 2010 Oct 25;49(44):8220-3
references.pmid: 20859977
references.citation: Bioconjug Chem. 2010 May 19;21(5):797-802
references.pmid: 20397686
references.citation: Biotechnol Bioeng. 1996 Oct 5;52(1):102-8
references.pmid: 18629856
references.citation: J Control Release. 2006 Dec 1;116(3):322-9
references.pmid: 17109985
references.citation: Eur J Pharm Sci. 2008 Mar 3;33(3):241-51
references.pmid: 18207707
references.citation: J Biomed Mater Res A. 2006 Mar 15;76(4):773-80
references.pmid: 16345095
references.citation: Pharm Dev Technol. 1998 Feb;3(1):55-62
references.pmid: 9532600
references.citation: Pharm Res. 2007 Aug;24(8):1572-80
references.pmid: 17435970
references.citation: Nat Rev Drug Discov. 2003 May;2(5):347-60
references.pmid: 12750738
references.citation: Biomaterials. 2009 Sep;30(27):4752-62
references.pmid: 19520429
references.citation: Curr Drug Deliv. 2010 Jan;7(1):13-20
references.pmid: 19863483
references.citation: Angew Chem Int Ed Engl. 2006 Feb 13;45(8):1198-215
references.pmid: 16444775
references.citation: J Mater Sci Mater Med. 2008 May;19(5):1991-7
references.pmid: 17952565
references.citation: J Control Release. 2008 May 8;127(3):273-9
references.pmid: 18346807
references.citation: J Am Chem Soc. 2009 Mar 18;131(10):3658-67
references.pmid: 19226179
references.citation: Expert Rev Vaccines. 2011 Apr;10(4):539-50
references.pmid: 21506650
references.citation: Mol Pharm. 2005 Mar-Apr;2(2):129-38
references.pmid: 15804187
references.citation: Invest Radiol. 2004 Mar;39(3):131-7
references.pmid: 15076004